Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery

NCT00667901 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

15

Enrollment

OTHER

Sponsor class

Stopped All enrollment, treatment, follow-up \& data analysis completed

Conditions

Melanoma (Skin)

Interventions

DRUG: riluzole
GENETIC: protein expression analysis
GENETIC: reverse transcriptase-polymerase chain reaction
GENETIC: western blotting
OTHER: immunohistochemistry staining method
OTHER: laboratory biomarker analysis
OTHER: pharmacological study
PROCEDURE: neoadjuvant therapy
PROCEDURE: therapeutic conventional surgery

Sponsor

University of Medicine and Dentistry of New Jersey

Collaborators

[object Object]